Search
for
Sort by
Research 31–60 of 1000+
- Axitinib-induced repigmentation of grey hair in a patient with metastatic renal cell carcinoma
- Erlotinib-Associated Alopecia in a Lung Cancer Patient
- Anti-EGFR mechanism of action: antitumor effect and underlying cause of adverse events.
- A Case of Cicatricial Alopecia Associated with Erlotinib
- Hair graying and loss induced by imatinib mesylate
- Spotlight commentary: Navigating the cutaneous side effects of chemotherapy
- Tombo em João Pessoa dá força a Memorial da Arquitetura Paraibana
- Dermatologic adverse events in EGFR-TKIs: A real-world analysis.
- 061 Selective inhibition of tyrosine kinase 2 prevents and restores interleukin-12-induced hair follicle immune privilege collapse: a novel approach to alopecia areata therapy?
- A Case of Hair Change and Acneiform Eruption Induced by ZD1839 (Iressa$^{(R)}$)
- c-Kit - The Novel Receptor: Physiological Roles, Downstream Signaling and Implications in Cancer
- 3D organotypic skin models recapitulate autoantibody-driven pemphigus pathomechanisms and targeted therapeutic response
- Drug Repurposing Patent Applications April–June 2021
- A Case of Inflammatory Nonscarring Alopecia Associated With the Tyrosine Kinase Inhibitor Nilotinib
- Cell wall-associated ROOT HAIR SPECIFIC 10, a proline-rich receptor-like kinase, is a negative modulator of Arabidopsis root hair growth
- 014 Tyrosine Kinase 2 Inhibition Ameliorates the Phenotype of Lesional Alopecia Areata Scalp Skin Ex Vivo, and Reverses the Induction of Human Alopecia Areata in a Humanized Mouse Model
- 700 Tyrosine kinase 2 inhibition rescues hair follicles from IL-12–mediated immune privilege collapse and reverses the induction of human alopecia areata in a humanized mouse model
- Bioinformatic analysis of gene expression data reveals Src family protein tyrosine kinases as key players in androgenetic alopecia
- Tyrosine Kinase Inhibitors against Cancer: Their Safety in 216 Moroccan Patients
- Tyrosine Kinases in Autoimmune and Inflammatory Skin Diseases
- Keratosis Pilaris-like Eruption during Treatment of Chronic Myeloid Leukemia with Tyrosine Kinase Inhibitors: Literature Review and Report of a Case Related to Imatinib
- Tyrosine kinase Inhibitors in Dermatology: A Systemic Review
- Safety of Tyrosine Kinase Inhibitors in Patients With Differentiated Thyroid Cancer: Real-World Use of Lenvatinib and Sorafenib in Korea
- Retinoid-mediated stimulation of steroid sulfatase activity in myeloid leukemic cell lines requires RARα and RXR and involves the phosphoinositide 3-kinase and ERK-MAP kinase pathways
- Suppression of Wnt/β-catenin signaling by EGF receptor is required for hair follicle development
- The PDGF/PDGFR pathway as a drug target
- Dasatinib-Induced Leukotrichia in a Patient With Chronic Myelogenous Leukemia
- Activity of Sorafenib against Desmoid Tumor/Deep Fibromatosis
- Angelica gigas Nakai (Korean Dang-gui) Root Alcoholic Extracts in Health Promotion and Disease Therapy – active Phytochemicals and In Vivo Molecular Targets
- Inhibition of a signaling modality within the gp130 receptor enhances tissue regeneration and mitigates osteoarthritis